{"entity":{"type":"insider","cik":"0001757917","url":"/insider/0001757917","json_url":"/insider/0001757917.json","name":"Omega Fund VI, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2020-10-16","last":"2023-11-09","span_basis":"filed_date"},"name_variants":[{"name":"Omega Fund VI, L.P.","source":"filing","n_filings":5,"first_seen":"2020-10-16","last_seen":"2023-11-09"}],"transactions":[{"id":8630855,"accession":"0001209191-23-054913","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-054913","line_url":"/filing/0001209191-23-054913#line-3","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund VI GP Manager, Ltd.; Stampacchia Otello; Omega Fund VI, L.P.; Omega Fund VI GP, L.P.; Nessi Claudio","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":2157623.0,"shares_owned_after_display":"2,157,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider"},{"id":5431928,"accession":"0000899243-21-040245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-040245","line_url":"/filing/0000899243-21-040245#line-2","is_derivative":false,"issuer_cik":"0001361712","issuer_name":"Theseus Pharmaceuticals, Inc.","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001361712","owner_cik":null,"owner_name":"Paster Anne-Mari; Omega Fund VI GP Manager, Ltd.; Nessi Claudio; Omega Fund VI, L.P.; Stampacchia Otello","owner_display_name":"Paster Anne-Mari","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":711479.0,"shares_owned_after_display":"711,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-14","scope":"insider"},{"id":4943579,"accession":"0001567619-21-013660","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-013660","line_url":"/filing/0001567619-21-013660#line-1","is_derivative":false,"issuer_cik":"0001623715","issuer_name":"Imago BioSciences, Inc.","issuer_ticker":"IMGO","issuer_name_source":null,"issuer_url":"/issuer/0001623715","owner_cik":"0001757917","owner_name":"Omega Fund VI, L.P.","owner_display_name":"Omega Fund VI, L.P.","owner_url":"/insider/0001757917","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-19","scope":"insider"},{"id":4210376,"accession":"0001104659-21-003864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-003864","line_url":"/filing/0001104659-21-003864#line-1","is_derivative":false,"issuer_cik":"0001757917","issuer_name":"Omega Alpha SPAC","issuer_ticker":"OMEG","issuer_name_source":null,"issuer_url":"/issuer/0001757917","owner_cik":null,"owner_name":"Omega Fund VI GP, L.P.; Omega Alpha Management; Pearsall Alexandra; Omega Fund VI GP Manager, Ltd.; Omega Fund VI, L.P.","owner_display_name":"Omega Fund VI GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":501000.0,"shares_display":"501,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5010000.0,"total_display":"5,010,000.00","total_whole":"5,010,000","shares_owned_after":501000.0,"shares_owned_after_display":"501,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2912682,"accession":"0001209191-20-055014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055014","line_url":"/filing/0001209191-20-055014#line-2","is_derivative":false,"issuer_cik":"0001683553","issuer_name":"SPRUCE BIOSCIENCES, INC.","issuer_ticker":"SPRB","issuer_name_source":null,"issuer_url":"/issuer/0001683553","owner_cik":null,"owner_name":"Omega Fund VI GP Manager, Ltd.; Omega Fund VI GP, L.P.; Omega Fund VI, L.P.","owner_display_name":"Omega Fund VI GP Manager, Ltd.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":2161022.0,"shares_owned_after_display":"2,161,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001907108","name":"Lexeo Therapeutics, Inc.","url":"/issuer/0001907108","role":"Ten percent owner","n_filings":1,"first_seen":"2023-11-09","last_seen":"2023-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001745020","name":"Theseus Pharmaceuticals, Inc.","url":"/issuer/0001745020","role":"Other","n_filings":1,"first_seen":"2021-10-14","last_seen":"2021-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001623715","name":"Imago BioSciences, Inc.","url":"/issuer/0001623715","role":"Other","n_filings":1,"first_seen":"2021-07-19","last_seen":"2021-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001832010","name":"Omega Alpha SPAC","url":"/issuer/0001832010","role":"Ten percent owner","n_filings":1,"first_seen":"2021-01-13","last_seen":"2021-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001683553","name":"SPRUCE BIOSCIENCES, INC.","url":"/issuer/0001683553","role":"Other","n_filings":1,"first_seen":"2020-10-16","last_seen":"2020-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001757917","retrieved_at":"2026-08-24T15:00:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}